Neoleukin Therapeutics In... (NLTX)
NASDAQ: NLTX
· Real-Time Price · USD
3.49
0.05 (1.45%)
At close: Dec 18, 2023, 10:00 PM
Neoleukin Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 70.77M | 136.59M | 66.63M | 111.03M | 25.23M | 31.11M | 35.49M | 37.89M | 40.34M | 77.53M | 128.06M | 142.47M | 154.92M | 164.24M | 178.39M |
Short-Term Investments | 221.83M | 175.82M | 72.36M | 42.87M | 53.28M | 50.95M | 47.94M | 58.5M | 66.54M | 38.93M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.24M | 1.31M | 1.13M | 1.13M | 524K | 529K | 905K | 936K | 1.91M | 2.02M | 1.95M | 1.93M | 1.99M | 1.93M | 1.92M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.8M | 3.52M | 4.65M | 5.24M | 1.39M | 1.72M | 2.2M | 2.75M | 1.98M | 2.03M | 2.31M | 1.52M | 1.57M | 3.26M | 2.92M |
Total Current Assets | 296.4M | 315.92M | 143.65M | 159.15M | 79.89M | 83.78M | 85.64M | 99.13M | 108.86M | 118.48M | 130.37M | 143.99M | 156.5M | 167.5M | 181.31M |
Property-Plant & Equipment | 17.67M | 18.49M | 19.34M | 19.54M | 9.17M | 9.7M | 11.92M | 15.88M | 15.81M | 16.5M | 16.74M | 17.22M | 17.27M | 17.36M | 16.58M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18K | 73K | 128K | 183K | 238K | 293K |
Total Long-Term Assets | 18.9M | 19.81M | 20.47M | 20.67M | 9.69M | 10.22M | 12.82M | 16.81M | 17.72M | 18.54M | 18.76M | 19.27M | 19.44M | 19.53M | 18.8M |
Total Assets | 315.3M | 335.73M | 164.12M | 179.82M | 89.59M | 94M | 98.46M | 115.95M | 126.58M | 137.02M | 149.13M | 163.26M | 175.93M | 187.02M | 200.1M |
Account Payables | 3.06M | 1.34M | 1.68M | 1.72M | n/a | n/a | n/a | 478K | 8.86M | 7.89M | 6.33M | 526K | 7.77M | 6.41M | 7.31M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.86M | -7.89M | -6.33M | n/a | -7.77M | -6.41M | -7.31M |
Short-Term Debt | 3.08M | 3M | 2.91M | 2.82M | 1.55M | 1.49M | 1.74M | 1.51M | 1.38M | 1.39M | 1.27M | 1.22M | 1.22M | 1.18M | 1.1M |
Other Current Liabilities | 7.95M | 10.82M | 11.21M | 8.53M | 3.66M | 3.39M | 5.42M | 9.07M | 8.86M | 7.89M | 6.33M | 6.89M | 7.77M | 6.41M | 7.31M |
Total Current Liabilities | 14.09M | 15.16M | 15.8M | 13.07M | 5.21M | 4.88M | 7.16M | 11.06M | 10.24M | 9.27M | 7.6M | 8.64M | 9M | 7.58M | 8.41M |
Long-Term Debt | 8.62M | 9.43M | 10.21M | 10.97M | 9.14M | 9.55M | 9.95M | 10.55M | 10.69M | 11.04M | 11.44M | 11.76M | 12.07M | 12.37M | 12.73M |
Other Long-Term Liabilities | 789K | 769K | 697K | 768K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 9.41M | 10.2M | 10.91M | 11.74M | 9.14M | 9.55M | 9.95M | 10.55M | 10.69M | 11.04M | 11.44M | 11.76M | 12.07M | 12.37M | 12.73M |
Total Liabilities | 23.51M | 25.36M | 26.71M | 24.81M | 14.35M | 14.43M | 17.1M | 21.62M | 20.93M | 20.31M | 19.03M | 20.4M | 21.07M | 19.95M | 21.14M |
Total Debt | 11.71M | 12.43M | 13.12M | 13.79M | 10.69M | 11.04M | 11.68M | 12.07M | 12.07M | 12.43M | 12.71M | 12.98M | 13.29M | 13.54M | 13.83M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -284.94M | -262.3M | -242.78M | -222.57M | -471.87M | -467.34M | -465.26M | -451.06M | -437.61M | -424.54M | -408.85M | -393.5M | -378.33M | -362.88M | -347.76M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -13K | 18K | -21K | -92K | -72K | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 291.8M | 310.38M | 137.41M | 155.01M | 75.23M | 79.58M | 81.36M | 94.33M | 105.65M | 116.71M | 130.09M | 142.86M | 154.87M | 167.07M | 178.97M |
Total Investments | n/a | n/a | n/a | n/a | 53.28M | 50.95M | 47.94M | 58.5M | 66.54M | 38.93M | n/a | n/a | n/a | n/a | n/a |